0001209191-20-008865.txt : 20200212
0001209191-20-008865.hdr.sgml : 20200212
20200212171154
ACCESSION NUMBER: 0001209191-20-008865
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTSHULER DAVID
CENTRAL INDEX KEY: 0001550395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20605360
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001550395
ALTSHULER DAVID
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Global Research and CSO
Common Stock
2020-02-10
4
F
0
13308
240.95
D
57002
D
Common Stock
2020-02-11
4
S
0
1000
243.36
D
56002
D
Common Stock
2020-02-11
4
S
0
3400
244.89
D
52602
D
Common Stock
2020-02-11
4
S
0
5725
245.81
D
46877
D
Common Stock
2020-02-11
4
S
0
3472
246.73
D
43405
D
Common Stock
2020-02-11
4
S
0
2235
247.73
D
41170
D
Common Stock
2020-02-11
4
S
0
1200
248.50
D
39970
D
Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $243.36 (range $242.88 to $243.79).
Open market sales reported on this line occurred at a weighted average price of $244.89 (range $244.28 to $245.25).
Open market sales reported on this line occurred at a weighted average price of $245.81 (range $245.29 to $246.24).
Open market sales reported on this line occurred at a weighted average price of $246.73 (range $246.29 to $247.26).
Open market sales reported on this line occurred at a weighted average price of $247.73 (range $247.36 to $248.28).
Open market sales reported on this line occurred at a weighted average price of $248.50 (range $248.37 to $248.82).
/s/ Omar White, Attorney-in-Fact
2020-02-12